Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) Stock Information | RedChip

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP)


$13.2500
+0.0900 ( +1.38% ) 79.5K

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company'sĀ development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Market Data


Open


$13.2500

Previous close


$13.1600

Volume


79.5K

Market cap


$156.14M

Day range


$12.7070 - $13.4690

52 week range


$5.3000 - $61.9000

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Feb 06, 2024
8-k 8K-related 12 Feb 06, 2024
8-k 8K-related 80 Feb 05, 2024
8-k/a 8K-related 13 Feb 02, 2024
8-k 8K-related 16 Feb 01, 2024
8-k 8K-related 12 Jan 31, 2024
3 Insider transactions 1 Jan 30, 2024
4 Insider transactions 1 Jan 30, 2024
4 Insider transactions 1 Jan 30, 2024
4 Insider transactions 1 Jan 30, 2024

Latest News